Leapcure Announces Enhanced Portfolio


Applied Clinical Trials

Leapcure has announced an enhanced portfolio of services focused on the successful recruitment, enrollment, and sustained engagement of patients in clinical studies. They seek to improve the specific areas of public awareness, clinical feasibility, site selection, and recruitment. 

To learn more, click here. 

Related Videos
Greg Ball, Founder, ASAP Process Consulting image credit screen shot from video
Janice Chang, CEO, TransCelerate BioPharma @ video screenshot.
Applied Clinical Trials and LabConnect
Related Content
© 2024 MJH Life Sciences

All rights reserved.